cyc 202 has been researched along with Experimental Hepatoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, KS; Eom, YW; Ha, MJ; Kang, Y; Kim, SJ; Rhee, H; Yoon, JW | 1 |
1 other study(ies) available for cyc 202 and Experimental Hepatoma
Article | Year |
---|---|
Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells.
Topics: Animals; Apoptosis; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cell Death; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Activation; Enzyme Inhibitors; Kinetin; Liver Neoplasms, Experimental; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Purines; Rats; Retinoblastoma Protein; RNA, Messenger; Roscovitine; Transforming Growth Factor beta; Tumor Cells, Cultured | 1999 |